News Release: Volusia County Monoclonal Antibody Therapy Treatment Site Update
November 05, 2021
Ormond Beach, Fla. — The State of Florida successfully deployed and expanded state-run, lifesaving monoclonal antibody therapy treatment sites statewide. Throughout this process, the State has worked with a robust network of community partners to ensure the health care sector is equipped to administer monoclonal antibody therapy treatment to Floridians.
To support this transition of monoclonal antibody therapy treatment administration to locally operated providers, the state-supported monoclonal antibody therapy treatment site at Ormond Beach Senior Center, 351 Andrews Street in Volusia County, will close on November 5, 2021*.
Alternative monoclonal antibody therapy treatment locations in this area are listed below:
AdventHealth Daytona Beach
301 Memorial Medical Parkway
Daytona Beach, Florida
AdventHealth Deland
701 W. Plymouth Ave.
Deland, Florida
Halifax Health Medical Center
303 N. Clyde Morris Blvd.
Daytona Beach, Florida
AdventHealth New Smyrna Beach
401 Palmetto St.
New Smyrna Beach, Florida
AdventHealth Fish Memorial
1055 Saxon Blvd.
Orange City, Florida
Halifax Health /UF Health Medical Center of Deltona
3300 Halifax Crossings Blvd.
Deltona, Florida
Family Health Source
2160 Howland Blvd #110
Deltona, Florida
The Florida Department of Health will continue to allocate doses of monoclonal antibodies to health care providers with high utilization rates and will ensure inventory levels meet county demand.
Monoclonal Antibody Therapy Treatment Locator:
Monoclonal antibody therapy treatment locations can be found at FloridaHealthCOVID19.gov and by using the National Infusion Center Association’s treatment locator.
Benefits of Treatment:
Monoclonal antibodies help the immune system recognize and respond effectively to the COVID-19 virus.
Monoclonal antibody therapy treatment is for individuals who have contracted or been exposed to COVID-19. Monoclonal antibody therapy treatment can prevent severe illness, hospitalization, and death in high-risk patients who have contracted COVID-19. Specifically, it:
- Reduces the risk of death/hospitalization by 70%-85%.
- Reduces the risk of developing symptomatic disease by over 80%.
###
About the Florida Department of Health
The Florida Department of Health, nationally accredited by the Public Health Accreditation Board, works to protect, promote and improve the health of all people in Florida through integrated state, county and community efforts.
Follow us on Facebook, Instagram and Twitter at @HealthyFla. For more information, please visit www.FloridaHealth.gov.
*Please note the date of this release. Information provided may have changed depending on the time that has elapsed."
Connect with DOH